Summary

Clinical Data Analytics Market – Scope of Report
TMR’s report on the global clinical data analytics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global clinical data analytics market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global clinical data analytics market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the clinical data analytics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global clinical data analytics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global clinical data analytics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global clinical data analytics market.

The report delves into the competitive landscape of the global clinical data analytics market. Key players operating in the global clinical data analytics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global clinical data analytics market profiled in this report.

Key Questions Answered in Global clinical data analytics Market Report
• What is the sales/revenue generated by clinical data analytics across all regions during the forecast period?
• What are the opportunities in the global clinical data analytics market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Clinical Data Analytics Market – Research Objectives and Research Approach
The comprehensive report on the global clinical data analytics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global clinical data analytics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global clinical data analytics market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Clinical Data Analytics Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Clinical Data Analytics Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Clinical Data Analytics Market Analysis and Forecast, by Component
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Component, 2020-2034
6.3.1. Services
6.3.2. Solutions
6.4. Market Attractiveness, by Component
7. Global Clinical Data Analytics Market Analysis and Forecast, by Type
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Type, 2020-2034
7.3.1. Prescriptive
7.3.2. Descriptive
7.3.3. Predictive
7.4. Market Attractiveness, by Type
8. Global Clinical Data Analytics Market Analysis and Forecast, By Deployment Type
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, By Deployment Type, 2020-2034
8.3.1. On-premises
8.3.2. On-cloud
8.4. Market Attractiveness, By Deployment Type
9. Global Clinical Data Analytics Market Analysis and Forecast, by Application
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Application, 2020-2034
9.3.1. Quality Improvement and Clinical Benchmarking
9.3.2. Clinical Decision Support
9.3.3. Regulatory Reporting and Compliance
9.3.4. Comparative Analytics/Comparative Effectiveness
9.3.5. Precision Health
9.4. Market Attractiveness, by Application
10. Global Clinical Data Analytics Market Analysis and Forecast, by End-user
10.1. Introduction and Definitions
10.2. Key Findings/Developments
10.3. Market Value Forecast, by End-user, 2020-2034
10.3.1. Healthcare Payers
10.3.1.1. Public
10.3.1.2. Private
10.3.2. Healthcare Providers
10.3.2.1. Hospitals and Clinics
10.3.2.2. Ambulatory Surgical Centers
10.3.2.3. Diagnostic Imaging Centers
10.3.2.4. Others (Research Centers, etc.)
10.4. Market Attractiveness, by End-user
11. Global Clinical Data Analytics Market Analysis and Forecast, by Region
11.1. Key Findings
11.2. Market Value Forecast, by Region, 2020-2034
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
11.3. Market Attractiveness, by Region
12. North America Clinical Data Analytics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Component, 2020-2034
12.2.1. Services
12.2.2. Solutions
12.3. Market Attractiveness, by Component
12.4. Market Value Forecast, by Type, 2020-2034
12.4.1. Prescriptive
12.4.2. Descriptive
12.4.3. Predictive
12.5. Market Attractiveness, by Type
12.6. Market Value Forecast, By Deployment Type, 2020-2034
12.6.1. On-premises
12.6.2. On-cloud
12.7. Market Attractiveness, By Deployment Type
12.8. Market Value Forecast, by Application, 2020-2034
12.8.1. Quality Improvement and Clinical Benchmarking
12.8.2. Clinical Decision Support
12.8.3. Regulatory Reporting and Compliance
12.8.4. Comparative Analytics/Comparative Effectiveness
12.8.5. Precision Health
12.9. Market Attractiveness, by Application
12.10. Market Value Forecast, by End-user, 2020-2034
12.10.1. Healthcare Payers
12.10.1.1. Public
12.10.1.2. Private
12.10.2. Healthcare Providers
12.10.2.1. Hospitals and Clinics
12.10.2.2. Ambulatory Surgical Centers
12.10.2.3. Diagnostic Imaging Centers
12.10.2.4. Others (Research Centers, etc.)
12.11. Market Attractiveness, by End-user
12.12. Market Value Forecast, by Country/Sub-region, 2020-2034
12.12.1. U.S.
12.12.2. Canada
12.13. Market Attractiveness Analysis
12.13.1. By Component
12.13.2. By Type
12.13.3. By Deployment Type
12.13.4. By Application
12.13.5. By End-user
12.13.6. By Country
13. Europe Clinical Data Analytics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Component, 2020-2034
13.2.1. Services
13.2.2. Solutions
13.3. Market Attractiveness, by Component
13.4. Market Value Forecast, by Type, 2020-2034
13.4.1. Prescriptive
13.4.2. Descriptive
13.4.3. Predictive
13.5. Market Attractiveness, by Type
13.6. Market Value Forecast, By Deployment Type, 2020-2034
13.6.1. On-premises
13.6.2. On-cloud
13.7. Market Attractiveness, By Deployment Type
13.8. Market Value Forecast, by Application, 2020-2034
13.8.1. Quality Improvement and Clinical Benchmarking
13.8.2. Clinical Decision Support
13.8.3. Regulatory Reporting and Compliance
13.8.4. Comparative Analytics/Comparative Effectiveness
13.8.5. Precision Health
13.9. Market Attractiveness, by Application
13.10. Market Value Forecast, by End-user, 2020-2034
13.10.1. Healthcare Payers
13.10.1.1. Public
13.10.1.2. Private
13.10.2. Healthcare Providers
13.10.2.1. Hospitals and Clinics
13.10.2.2. Ambulatory Surgical Centers
13.10.2.3. Diagnostic Imaging Centers
13.10.2.4. Others (Research Centers, etc.)
13.11. Market Attractiveness, by End-user
13.12. Market Value Forecast, by Country/Sub-region, 2020-2034
13.12.1. Germany
13.12.2. U.K.
13.12.3. France
13.12.4. Italy
13.12.5. Spain
13.12.6. Rest of Europe
13.13. Market Attractiveness Analysis
13.13.1. By Component
13.13.2. By Type
13.13.3. By Deployment Type
13.13.4. By Application
13.13.5. By End-user
13.13.6. By Country/Sub-region
14. Asia Pacific Clinical Data Analytics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Component, 2020-2034
14.2.1. Services
14.2.2. Solutions
14.3. Market Attractiveness, by Component
14.4. Market Value Forecast, by Type, 2020-2034
14.4.1. Prescriptive
14.4.2. Descriptive
14.4.3. Predictive
14.5. Market Attractiveness, by Type
14.6. Market Value Forecast, By Deployment Type, 2020-2034
14.6.1. On-premises
14.6.2. On-cloud
14.7. Market Attractiveness, By Deployment Type
14.8. Market Value Forecast, by Application, 2020-2034
14.8.1. Quality Improvement and Clinical Benchmarking
14.8.2. Clinical Decision Support
14.8.3. Regulatory Reporting and Compliance
14.8.4. Comparative Analytics/Comparative Effectiveness
14.8.5. Precision Health
14.9. Market Attractiveness, by Application
14.10. Market Value Forecast, by End-user, 2020-2034
14.10.1. Healthcare Payers
14.10.1.1. Public
14.10.1.2. Private
14.10.2. Healthcare Providers
14.10.2.1. Hospitals and Clinics
14.10.2.2. Ambulatory Surgical Centers
14.10.2.3. Diagnostic Imaging Centers
14.10.2.4. Others (Research Centers, etc.)
14.11. Market Attractiveness, by End-user
14.12. Market Value Forecast, by Country/Sub-region, 2020-2034
14.12.1. China
14.12.2. Japan
14.12.3. India
14.12.4. Australia & New Zealand
14.12.5. Rest of Asia Pacific
14.13. Market Attractiveness Analysis
14.13.1. By Component
14.13.2. By Type
14.13.3. By Deployment Type
14.13.4. By Application
14.13.5. By End-user
14.13.6. By Country/Sub-region
15. Latin America Clinical Data Analytics Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Component, 2020-2034
15.2.1. Services
15.2.2. Solutions
15.3. Market Attractiveness, by Component
15.4. Market Value Forecast, by Type, 2020-2034
15.4.1. Prescriptive
15.4.2. Descriptive
15.4.3. Predictive
15.5. Market Attractiveness, by Type
15.6. Market Value Forecast, By Deployment Type, 2020-2034
15.6.1. On-premises
15.6.2. On-cloud
15.7. Market Attractiveness, By Deployment Type
15.8. Market Value Forecast, by Application, 2020-2034
15.8.1. Quality Improvement and Clinical Benchmarking
15.8.2. Clinical Decision Support
15.8.3. Regulatory Reporting and Compliance
15.8.4. Comparative Analytics/Comparative Effectiveness
15.8.5. Precision Health
15.9. Market Attractiveness, by Application
15.10. Market Value Forecast, by End-user, 2020-2034
15.10.1. Healthcare Payers
15.10.1.1. Public
15.10.1.2. Private
15.10.2. Healthcare Providers
15.10.2.1. Hospitals and Clinics
15.10.2.2. Ambulatory Surgical Centers
15.10.2.3. Diagnostic Imaging Centers
15.10.2.4. Others (Research Centers, etc.)
15.11. Market Attractiveness, by End-user
15.12. Market Value Forecast, by Country/Sub-region, 2020-2034
15.12.1. Brazil
15.12.2. Mexico
15.12.3. Rest of Latin America
15.13. Market Attractiveness Analysis
15.13.1. By Component
15.13.2. By Type
15.13.3. By Deployment Type
15.13.4. By Application
15.13.5. By End-user
15.13.6. By Country/Sub-region
16. Middle East & Africa Clinical Data Analytics Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast, by Component, 2020-2034
16.2.1. Services
16.2.2. Solutions
16.3. Market Attractiveness, by Component
16.4. Market Value Forecast, by Type, 2020-2034
16.4.1. Prescriptive
16.4.2. Descriptive
16.4.3. Predictive
16.5. Market Attractiveness, by Type
16.6. Market Value Forecast, By Deployment Type, 2020-2034
16.6.1. On-premises
16.6.2. On-cloud
16.7. Market Attractiveness, By Deployment Type
16.8. Market Value Forecast, by Application, 2020-2034
16.8.1. Quality Improvement and Clinical Benchmarking
16.8.2. Clinical Decision Support
16.8.3. Regulatory Reporting and Compliance
16.8.4. Comparative Analytics/Comparative Effectiveness
16.8.5. Precision Health
16.9. Market Attractiveness, by Application
16.10. Market Value Forecast, by End-user, 2020-2034
16.10.1. Healthcare Payers
16.10.1.1. Public
16.10.1.2. Private
16.10.2. Healthcare Providers
16.10.2.1. Hospitals and Clinics
16.10.2.2. Ambulatory Surgical Centers
16.10.2.3. Diagnostic Imaging Centers
16.10.2.4. Others (Research Centers, etc.)
16.11. Market Attractiveness, by End-user
16.12. Market Value Forecast, by Country/Sub-region, 2020-2034
16.12.1. GCC Countries
16.12.2. South Africa
16.12.3. Rest of Middle East & Africa
16.13. Market Attractiveness Analysis
16.13.1. By Component
16.13.2. By Type
16.13.3. By Deployment Type
16.13.4. By Application
16.13.5. By End-user
16.13.6. By Country/Sub-region
17. Competition Landscape
17.1. Market Player - Competition Matrix (By Tier and Size of Companies)
17.2. Market Share Analysis, by Company (2023)
17.3. Company Profiles
17.3.1. CareEvolution
17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.1.2. Product Portfolio
17.3.1.3. Financial Overview
17.3.1.4. SWOT Analysis
17.3.1.5. Strategic Overview
17.3.2. Veradigm
17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.2.2. Product Portfolio
17.3.2.3. Financial Overview
17.3.2.4. SWOT Analysis
17.3.2.5. Strategic Overview
17.3.3. IQVIA
17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.3.2. Product Portfolio
17.3.3.3. Financial Overview
17.3.3.4. SWOT Analysis
17.3.3.5. Strategic Overview
17.3.4. Oracle
17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.4.2. Product Portfolio
17.3.4.3. Financial Overview
17.3.4.4. SWOT Analysis
17.3.4.5. Strategic Overview
17.3.5. Health Catalyst
17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.5.2. Product Portfolio
17.3.5.3. Financial Overview
17.3.5.4. SWOT Analysis
17.3.5.5. Strategic Overview
17.3.6. IBM
17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.6.2. Product Portfolio
17.3.6.3. Financial Overview
17.3.6.4. SWOT Analysis
17.3.6.5. Strategic Overview
17.3.7. InterSystems Corporation
17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.7.2. Product Portfolio
17.3.7.3. Financial Overview
17.3.7.4. SWOT Analysis
17.3.7.5. Strategic Overview
17.3.8. Optum, Inc.
17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.8.2. Product Portfolio
17.3.8.3. Financial Overview
17.3.8.4. SWOT Analysis
17.3.8.5. Strategic Overview
17.3.9. Koninklijke Philips N.V.
17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.9.2. Product Portfolio
17.3.9.3. Financial Overview
17.3.9.4. SWOT Analysis
17.3.9.5. Strategic Overview
17.3.10. MedeAnalytics
17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.10.2. Product Portfolio
17.3.10.3. Financial Overview
17.3.10.4. SWOT Analysis
17.3.10.5. Strategic Overview
17.3.11. Sisense
17.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.11.2. Product Portfolio
17.3.11.3. Financial Overview
17.3.11.4. SWOT Analysis
17.3.11.5. Strategic Overview